How to Buy Minerva Neurosciences Stock
Minerva Neurosciences Inc
Minerva Neurosciences, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases.
Minerva Neurosciences stock last closed at $1.66, up 3.75% from the previous day, and has decreased 34.9% in one year. It has overperformed other stocks in the Biotechnology industry by 0.43 percentage points. Minerva Neurosciences stock is currently +44.35% from its 52-week low of $1.15, and -55.01% from its 52-week high of $3.69.
There are currently 6.99M NERV shares outstanding. The market cap of NERV is $11.61M. In the last 24 hours, 21,119 NERV shares were traded.
How to Buy Minerva Neurosciences Stock
Not sure how to invest in Minerva Neurosciences stock? Here's how.
- Choose where to buy Minerva Neurosciences stock: You need to pick a stock brokerage, but don't worry - we've researched dozens of stock brokerages and apps to help you determine where to buy Minerva Neurosciences stock.
- Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've selected.
- Deposit funds into your brokerage account: Choose your payment method and add your info.
- Analyze Minerva Neurosciences stock: The Minerva Neurosciences ticker symbol is NERV. Is Minerva Neurosciences stock a good investment? Should you buy shares of NERV? How do NERV's underlying business fundamentals look? Do top analysts think Minerva Neurosciences is a good buy? Why has NERV's stock price moved recently? (Hint: Our stock market analysis website can help you decide if NERV is a good stock to buy).
- Make your NERV trade: Decide if you will purchase NERV shares at the current market price or use a limit order to buy NERV stock at a specific price.
- Get key alerts regarding your investment in NERV: Create a watchlist to important notifications about your investment in Minerva Neurosciences shares.
Step 1: Choose where to buy Minerva Neurosciences stock
You will need a brokerage account to access the NASDAQ market and buy NERV stock.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best stock brokerage. Here's why:
- You can invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
- Access to global markets: From Technology to Utilities, New York to London (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top exchanges.
- Social investing: eToro has a community with more than 20 million users globally. Talk to, learn from, and copy the crypto trades of top investors.
- Security: eToro is a regulated and licensed brokerage platform.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by creating an account with eToro today. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've picked the right brokerage, the next step is to fill out some personal details so you are able to invest in NERV today.
How to Start a New Brokerage Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Enter your personal details to create a new trading account.
- Submit your application by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you have finished signing up on the best stock buying app, you can securely and quickly fund your account:
Check out this video walkthrough to see the process of depositing funds into your brokerage account.
Step 4: Analyze Minerva Neurosciences stock
Once you have decided on the best place to buy Minerva Neurosciences stock, it's critical to analyze their stock before you invest, so you can comprehend the risk as well as the opportunity.
Minerva Neurosciences stock data
NERV Overview
WallStreetZen was built to help part-time investors do more in-depth fundamental analysis in less time.
You can see all of the due diligence checks on NERV's stock page.
Is NERV stock undervalued?
Analysts use a variety of different financial metrics, analyses, models, and charts to gauge NERV's intrinsic value.
Using relative valuations metrics:
- NERV could be undervalued based on its P/E ratio of 8.74x, relative to Biotechnology industry P/E ratio of -184.27x
You can access more valuation analysis on NERV's stock here.
NERV Financial Overview
Passed Financial Due Diligence Checks:
- NERV has cash burn of 19550567. It has sufficient cash and short-term investments to cover this for at least one year.
- There are more short-term assets than short-term liabilities on the NERV balance sheet.
- NERV has $21.46M in cash and short term investments. This is enough to cover its annual cash burn of $19.55M.
Failed Financial Due Diligence Checks:
- Total NERV debt is still negative.
- There are more long-term liabilities than short-term assets on the NERV balance sheet.
- NERV debt to equity ratio of -2.45 is negative.
Is Minerva Neurosciences stock a Buy, Hold, or Sell, according to Wall Street analysts?
Out of 1 sell side analysts who give recommendations on NERV, the consensus analyst rating on NERV is a Hold
Please note that analyst ratings are not recommendations, nor are they investment advice.
You can dive deeper into what analysts are projecting on the Minerva Neurosciences stock forecast page.
Metrics for Advanced NERV Traders
NERV Performance Numbers
Last year, NERV earnings were $1.44M. During the last four year, NERV's earnings have gone up by -16.98% per year. This was slower than the Biotechnology industry average of 10.61%.
Last year, NERV revenue was $0.00. In the past 4 year, NERV's revenue has gone up by -100% per year. This was slower than the Biotechnology industry average of 44.31%.
Find out more about NERV's earnings and revenue performance here.
Who is buying/selling NERV?
Over the past 12 months, insiders at NERV have not bought or sold any shares.
Learn more about who owns NERV stock here.
Can I rely on NERV as an income stream?
No, Minerva Neurosciences doesn't provide an income stream by paying out dividends.
What do other investors have to say about NERV?
One of the biggest reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Make your NERV trade
There are two main order types:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are mostly sufficient. - Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
If you want to be sure you're buying or selling at a given dollar amount limit, place a limit order.
Click the Open Trade button and eToro will place the order.
If you want additional help with buying stocks on eToro, watch the how to video below:
Step 6: Get key alerts regarding your investment in NERV
Now that you own some NERV shares, you'll want to stay up-to-date on your shares.
Create a watchlist to get notified of the latest news about your NERV stock.
NERV Feed
How to Buy Stock in Minerva Neurosciences
To reiterate, here are the 6 steps for buying Minerva Neurosciences stock:
- Choose where to buy Minerva Neurosciences stock
- Sign up for a brokerage account
- Deposit funds into your brokerage account
- Analyze Minerva Neurosciences stock
- Make your NERV trade
- Get key alerts regarding your investment in NERV
If you require a brokerage, eToro is our favorite venue.
Get Started with eToro TodayIf you want to get the latest scoop on your investment in Minerva Neurosciences, create a watchlist today.
More Content You May Enjoy
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.